Vor bio to present at b. riley securities' 3rd annual oncology conference

Cambridge, mass., jan. 12, 2023 (globe newswire) -- vor biopharma (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that it will participate virtually in b. riley securities' 3rd annual oncology conference.

VOR Ratings Summary

VOR Quant Ranking